These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11520198)

  • 21. Antioxidant and cytoprotective activity of indole derivatives related to melatonin.
    Mor M; Spadoni G; Diamantini G; Bedini A; Tarzia G; Silva C; Vacondio F; Rivara M; Plazzi PV; Franceschini D; Zusso M; Giusti P
    Adv Exp Med Biol; 2003; 527():567-75. PubMed ID: 15206775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin.
    Mor M; Plazzi PV; Spadoni G; Tarzia G
    Curr Med Chem; 1999 Jun; 6(6):501-18. PubMed ID: 10213796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of melatonin receptors agonists and antagonists.
    Tarzia G; Diamantini G; Mor M; Spadoni G
    Farmaco; 2000 Mar; 55(3):184-7. PubMed ID: 10919077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GR196429: a nonindolic agonist at high-affinity melatonin receptors.
    Beresford IJ; Browning C; Starkey SJ; Brown J; Foord SM; Coughlan J; North PC; Dubocovich ML; Hagan RM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1239-45. PubMed ID: 9618428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats.
    Ting KN; Blaylock NA; Sugden D; Delagrange P; Scalbert E; Wilson VG
    Br J Pharmacol; 1999 Jun; 127(4):987-95. PubMed ID: 10433507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of N1-phenethyl substituted indole derivatives as new melatoninergic agonists and antagonists.
    Tsotinis A; Vlachou M; Eleutheriades A; Prinea E; Ebreo D; The MT; Sugden D
    Chem Pharm Bull (Tokyo); 2002 Jan; 50(1):31-9. PubMed ID: 11824582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
    Spadoni G; Bedini A; Lucarini S; Mari M; Caignard DH; Boutin JA; Delagrange P; Lucini V; Scaglione F; Lodola A; Zanardi F; Pala D; Mor M; Rivara S
    J Med Chem; 2015 Sep; 58(18):7512-25. PubMed ID: 26334942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production and characterization of antibodies directed against the human melatonin receptors Mel-1a (mt1) and Mel-1b (MT2).
    Angeloni D; Longhi R; Fraschini F
    Eur J Histochem; 2000; 44(2):199-204. PubMed ID: 10968369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin receptor subtype MT2 (Mel 1b) and not mt1 (Mel 1a) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity.
    Drazen DL; Nelson RJ
    Neuroendocrinology; 2001 Sep; 74(3):178-84. PubMed ID: 11528219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin decreases cell proliferation and transformation in a melatonin receptor-dependent manner.
    Jones MP; Melan MA; Witt-Enderby PA
    Cancer Lett; 2000 Apr; 151(2):133-43. PubMed ID: 10738107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-affinity relationships of indole-based melatonin analogs.
    Spadoni G; Mor M; Tarzia G
    Biol Signals Recept; 1999; 8(1-2):15-23. PubMed ID: 10085458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).
    Leclerc V; Yous S; Delagrange P; Boutin JA; Renard P; Lesieur D
    J Med Chem; 2002 Apr; 45(9):1853-9. PubMed ID: 11960497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological characterization of the human melatonin Mel1a receptor following stable transfection into NIH3T3 cells.
    Nonno R; Lucini V; Pannacci M; Mazzucchelli C; Angeloni D; Fraschini F; Stankov BM
    Br J Pharmacol; 1998 Jun; 124(3):485-92. PubMed ID: 9647472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indanyl piperazines as melatonergic MT2 selective agents.
    Mattson RJ; Catt JD; Keavy D; Sloan CP; Epperson J; Gao Q; Hodges DB; Iben L; Mahle CD; Ryan E; Yocca FD
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1199-202. PubMed ID: 12643943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of novel beta-substituted indol-3-yl ethylamido melatoninergic analogues.
    Iakovou K; Varvaresou A; Kourounakis AP; Stead K; Sugden D; Tsotinis A
    J Pharm Pharmacol; 2002 Jan; 54(1):147-56. PubMed ID: 11829126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, enantiomeric resolution, and structure-activity relationship study of a series of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene MT2 receptor antagonists.
    Spadoni G; Bedini A; Diamantini G; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Caronno A; Fraschini F
    ChemMedChem; 2007 Dec; 2(12):1741-9. PubMed ID: 17907131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammalian melatonin receptors: molecular biology and signal transduction.
    von Gall C; Stehle JH; Weaver DR
    Cell Tissue Res; 2002 Jul; 309(1):151-62. PubMed ID: 12111545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands.
    Leclerc V; Fourmaintraux E; Depreux P; Lesieur D; Morgan P; Howell HE; Renard P; Caignard DH; Pfeiffer B; Delagrange P; Guardiola-Lemaître B; Andrieux J
    Bioorg Med Chem; 1998 Oct; 6(10):1875-87. PubMed ID: 9839017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of potent N1-substituted indole melatonin receptor agonists.
    Tsotinis A; Eleutheriades A; Hough K; Sugden D
    Chem Commun (Camb); 2003 Feb; (3):382-3. PubMed ID: 12613623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.